<p>Pfizer and Moderna's Covid-19 vaccines may soon come to India as the government is likely to clear the pending indemnity clause that was causing delays in the emergency use nod.<br /><br />"It is expected to grant indemnity against legal proceedings along the lines of what has been granted in other countries for Pfizer and Moderna vaccine companies," <em>ANI</em> <a href="https://twitter.com/ANI/status/1399970116784201733" target="_blank">quoted</a> government sources as saying.</p>.<p><strong><a data-sk="tooltip_parent" data-stringify-link="http://www.deccanherald.com/tag/covid-19" delay="150" href="http://www.deccanherald.com/tag/covid-19" rel="noopener noreferrer" target="_blank">SPECIAL CORONAVIRUS COVERAGE ONLY ON DH</a></strong></p>.<p> The pharma giants had sought from the government indemnity from costs relating to severe vaccine side-effects.</p>.<p> India's apex drug regulator has also waived the requirement of testing every batch of foreign-made Covid-19 vaccines by the Central Drugs Laboratory, Kasauli and post-launch bridging trials for such firms, a move that will bolster availability of vaccines.</p>.<p>The decision by the Drugs Controller General of India (DCGI) comes in the backdrop of Pfizer and Cipla putting forth similar demands during negotiations to supply imported vaccines to India.</p>.<p><em><strong>More to follow...</strong></em></p>.<p>(With agency inputs)</p>
<p>Pfizer and Moderna's Covid-19 vaccines may soon come to India as the government is likely to clear the pending indemnity clause that was causing delays in the emergency use nod.<br /><br />"It is expected to grant indemnity against legal proceedings along the lines of what has been granted in other countries for Pfizer and Moderna vaccine companies," <em>ANI</em> <a href="https://twitter.com/ANI/status/1399970116784201733" target="_blank">quoted</a> government sources as saying.</p>.<p><strong><a data-sk="tooltip_parent" data-stringify-link="http://www.deccanherald.com/tag/covid-19" delay="150" href="http://www.deccanherald.com/tag/covid-19" rel="noopener noreferrer" target="_blank">SPECIAL CORONAVIRUS COVERAGE ONLY ON DH</a></strong></p>.<p> The pharma giants had sought from the government indemnity from costs relating to severe vaccine side-effects.</p>.<p> India's apex drug regulator has also waived the requirement of testing every batch of foreign-made Covid-19 vaccines by the Central Drugs Laboratory, Kasauli and post-launch bridging trials for such firms, a move that will bolster availability of vaccines.</p>.<p>The decision by the Drugs Controller General of India (DCGI) comes in the backdrop of Pfizer and Cipla putting forth similar demands during negotiations to supply imported vaccines to India.</p>.<p><em><strong>More to follow...</strong></em></p>.<p>(With agency inputs)</p>